The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
about
Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.Ex vivo model of an immobilized-enzyme reactor.Hydration effects of heparin on antithrombin probed by osmotic stress.Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin timeStructural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model buildingDabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.The emerging role of coagulation proteases in kidney disease.Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.The acceleration of the inhibition of platelet prothrombinase complex by heparin.Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.Heparan sulfate/heparin glycosaminoglycan binding alters inhibitory profile and enhances anticoagulant function of conserved Amblyomma americanum tick saliva serpin 19.Influence of Layer-by-Layer Polyelectrolyte Deposition and EDC/NHS Activated Heparin Immobilization onto Silk Fibroin Fabric.Replacement of Phe274 with conserved residue Tyr274 for reactive center loop expulsion in antithrombin.Glycosaminoglycans and the regulation of blood coagulation.Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombinEffect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity.The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.Binding and growth-inhibitory effect of heparin and oligo-heparin (2kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover.Mechanism of inactivation of trypsin by antithrombin.The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor XaThe relative molecular mass dependence of the anti-factor Xa properties of heparin.Complex-formation and inhibition of urokinase by blood plasma proteins.Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.The influence of hindered transport on the development of platelet thrombi under flow.In vivo-generated thrombin and plasmin do not activate the complement system in baboons.
P2860
Q30419367-2827FA60-BE0D-439A-9DBF-52EC06F44D43Q33399576-DC151ADB-D13C-47F3-B9EF-5F8D1F1AAE19Q33519982-CC4D567F-4442-4B23-A696-7D8A0272930DQ33673352-1295A94E-EF84-4810-A54F-B9668C40C57FQ34177270-8D99B3E2-563E-4417-8951-501E402CBC71Q34550218-514EACE8-BDE8-474E-A8A5-2E736DDD3B26Q35056506-0C79C6B6-ABD5-4C63-938A-3F77F50A7565Q36152281-6F6AB230-AAA5-44B7-BA8A-B2B04D781E80Q36279827-22A73B9B-F327-4EF9-A1D1-818E9A566F1DQ36548878-47984E73-2AC5-448D-BC30-4488026621D3Q36992682-1C5DC13E-961E-40D4-BCF3-4C050A6F5324Q37066587-42EAAA14-2598-457C-8C96-49D8A95918F0Q37348302-4BC2B526-EAD0-4FD9-B4C1-69796C34651DQ38351431-78B438CD-FBB9-4A5C-8AB3-339A8A55F449Q38353478-8C1278B3-6CC6-4B8F-AA60-97A2D8E3602FQ39187267-43574847-4B13-49B1-9E12-065E4A23D2CEQ39213106-504C8C92-D1AF-425A-8510-8DBC6334C85AQ39730786-FB5DED04-10E8-4A84-8A1E-81BA8F0CF3C8Q40851193-954BC8A2-0592-4281-94DA-4466A8397113Q40927170-74BDE758-AF16-46B2-A146-BC3E5E6F51BEQ41350200-250C96B7-D2A1-4697-AA01-7FE730B602B7Q41837305-98B36BF2-6C7C-497B-8C36-9C55E9D0AD52Q41839110-72E3D112-7C37-45D7-B4FE-46BD64CA6136Q41878618-5D6A8F20-4DB7-43CE-823C-93453823775BQ41942060-FAB9E421-0C06-4040-BEE6-B4644C04FA95Q42154755-E0CCAF57-6C9C-4CE5-A893-DB98A06121E6Q42368773-E09FD914-BF91-4B38-BBB9-421C4E057DE5Q42673196-2C88DFBE-96AB-4845-B1DE-DAEDE5CADBF9Q42792885-671A4E9E-CE89-47B1-8B04-228A4666D8CDQ42802874-2C7E7DE1-8D5F-43FF-95F7-1BB6737357B6Q42854432-D1C2B99F-1FA9-48B3-BF39-1FE0CC79E55FQ42865484-2A6D3025-28B3-4862-ABF6-AC0CB0FC7D50Q42869661-DBBE4187-DAB5-4CA1-BB34-A378F0459999Q46207575-C77E7AAE-04D2-40FC-AC27-9B17295F1772Q47665964-38F70E3C-E24C-4ADF-8A7B-AAAE7D1689CD
P2860
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
description
1980 nî lūn-bûn
@nan
1980 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
The kinetics of hemostatic enz ...... low molecular weight heparin.
@ast
The kinetics of hemostatic enz ...... low molecular weight heparin.
@en
The kinetics of hemostatic enz ...... low molecular weight heparin.
@nl
type
label
The kinetics of hemostatic enz ...... low molecular weight heparin.
@ast
The kinetics of hemostatic enz ...... low molecular weight heparin.
@en
The kinetics of hemostatic enz ...... low molecular weight heparin.
@nl
prefLabel
The kinetics of hemostatic enz ...... low molecular weight heparin.
@ast
The kinetics of hemostatic enz ...... low molecular weight heparin.
@en
The kinetics of hemostatic enz ...... low molecular weight heparin.
@nl
P2093
P1476
The kinetics of hemostatic enz ...... low molecular weight heparin.
@en
P2093
Gardner WT
Rosenberg RD
P304
10081-10090
P407
P577
1980-11-01T00:00:00Z